DE602005026724D1 - Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz-kreislauf-leiden - Google Patents
Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz-kreislauf-leidenInfo
- Publication number
- DE602005026724D1 DE602005026724D1 DE602005026724T DE602005026724T DE602005026724D1 DE 602005026724 D1 DE602005026724 D1 DE 602005026724D1 DE 602005026724 T DE602005026724 T DE 602005026724T DE 602005026724 T DE602005026724 T DE 602005026724T DE 602005026724 D1 DE602005026724 D1 DE 602005026724D1
- Authority
- DE
- Germany
- Prior art keywords
- cells
- sleeping
- fat
- treatment
- regenerative cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2005/018605 WO2006127007A2 (en) | 2005-05-25 | 2005-05-25 | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005026724D1 true DE602005026724D1 (de) | 2011-04-14 |
Family
ID=37452485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005026724T Active DE602005026724D1 (de) | 2005-05-25 | 2005-05-25 | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz-kreislauf-leiden |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP2465923B1 (de) |
JP (1) | JP5210155B2 (de) |
KR (2) | KR101400544B1 (de) |
CN (1) | CN101443023A (de) |
AT (1) | ATE500319T1 (de) |
AU (1) | AU2005332046B2 (de) |
CA (1) | CA2609361C (de) |
DE (1) | DE602005026724D1 (de) |
DK (1) | DK1885382T3 (de) |
ES (1) | ES2364689T3 (de) |
PL (1) | PL1885382T3 (de) |
WO (1) | WO2006127007A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
CA2849201A1 (en) | 2001-12-07 | 2003-07-03 | Macropore Biosurgery, Inc. | Adipose-derived cell processing unit |
US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
US7780649B2 (en) | 2005-03-23 | 2010-08-24 | Shippert Ronald D | Tissue transplantation method and apparatus |
US7794449B2 (en) | 2005-03-23 | 2010-09-14 | Shippert Ronald D | Tissue transplantation method and apparatus |
US9581942B1 (en) | 2005-03-23 | 2017-02-28 | Shippert Enterprises, Llc | Tissue transfer method and apparatus |
US8622997B2 (en) | 2005-03-23 | 2014-01-07 | Ronald D. Shippert | Tissue transfer method and apparatus |
US7789872B2 (en) | 2005-03-23 | 2010-09-07 | Shippert Ronald D | Tissue transplantation method and apparatus |
US8062286B2 (en) | 2005-03-23 | 2011-11-22 | Shippert Ronald D | Tissue transplantation method and apparatus |
ES2325715B1 (es) | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca. |
WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
KR101679671B1 (ko) * | 2009-10-27 | 2016-11-28 | 도병록 | 재생성 세포 추출 시스템 |
US8887770B1 (en) | 2011-03-17 | 2014-11-18 | Ronald D. Shippert | Vessel fill control method and apparatus |
CN102151153A (zh) * | 2011-03-25 | 2011-08-17 | 吴成翰 | 外科手术过程中组织碎片的回收装置 |
JP5628131B2 (ja) * | 2011-10-19 | 2014-11-19 | サイトリ セラピューティクス インコーポレイテッド | 心血管状態の治療において脂肪組織由来細胞を使用する方法 |
DE102013209718B4 (de) * | 2012-06-22 | 2015-09-10 | Human Med Ag | Vorrichtung zum Separieren von adulten Stammzellen |
US9259435B2 (en) | 2012-08-31 | 2016-02-16 | W. L. Gore & Associates, Inc. | Reactive oxidative species generating materials and methods of use |
US9468709B2 (en) | 2012-11-12 | 2016-10-18 | Shippert Enterprises, Llc | Syringe fill method and apparatus |
US9580678B2 (en) | 2013-06-21 | 2017-02-28 | The Regents Of The University Of California | Microfluidic tumor tissue dissociation device |
CN106068124A (zh) * | 2014-02-28 | 2016-11-02 | Bdbc科学公司 | 一种用于组织操作的系统 |
US10772997B2 (en) | 2014-05-15 | 2020-09-15 | Ronald D. Shippert | Tissue parcelization method and apparatus |
DE102015109148B3 (de) * | 2015-06-10 | 2016-05-04 | Human Med Ag | Vorrichtung zum Separieren von regenerativen und adulten Stammzellen |
CN106318905A (zh) * | 2015-07-10 | 2017-01-11 | 中国科学院上海生命科学研究院 | 血栓烷素a2受体作为脂肪干细胞治疗缺血性疾病的靶标 |
SG11201806177QA (en) * | 2016-01-19 | 2018-08-30 | Univ Osaka | Transplant material for treatment of heart disease |
US10722540B1 (en) | 2016-02-01 | 2020-07-28 | The Regents Of The University Of California | Microfluidic device and method for shear stress-induced transformation of cells |
CN109564231B (zh) | 2016-06-08 | 2023-01-06 | 加利福尼亚大学董事会 | 用于处理组织和细胞的方法和装置 |
JP6256786B1 (ja) * | 2017-04-12 | 2018-01-10 | 学校法人福岡大学 | 不妊症の処置に用いられる医薬組成物およびその製造方法 |
CN107988151A (zh) * | 2017-12-06 | 2018-05-04 | 北京大学第三医院 | 一种体外诱导带血管蒂的脂肪组织成肌方法 |
JP2023514080A (ja) * | 2020-02-04 | 2023-04-05 | ヒエラバイオ インコーポレイテッド | 幹細胞を含む心膜内注入用組成物およびその用途 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US482820A (en) | 1892-09-20 | Ernest p | ||
US6238908B1 (en) | 1995-06-07 | 2001-05-29 | Aastrom Biosciences, Inc. | Apparatus and method for maintaining and growth biological cells |
FR2742662B1 (fr) | 1995-12-21 | 1998-01-23 | Centre Nat Rech Scient | Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments |
US6280473B1 (en) | 1996-08-19 | 2001-08-28 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US5919234A (en) | 1996-08-19 | 1999-07-06 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
DK1007631T4 (da) * | 1997-07-14 | 2009-04-27 | Osiris Therapeutics Inc | Hjertemuskelregeneration ved anvendelse af mesenkymale stamceller |
US6269716B1 (en) | 1998-11-18 | 2001-08-07 | Macropore, Inc. | High-torque resorbable screws |
JP2002510530A (ja) | 1998-04-07 | 2002-04-09 | マクロポア インコーポレイテッド | 組織案内表面波形部付きのメンブレン |
US6001642A (en) | 1998-06-29 | 1999-12-14 | Wyle Laboratories, Inc. Life Sciences | Bioreactor and cell culturing processes using the bioreactor |
WO2001036663A2 (en) | 1999-11-15 | 2001-05-25 | Chemclean Corporation | Bio-burden visualization system |
EP1852087B1 (de) | 2000-03-10 | 2011-05-11 | MAST Biosurgery AG | Resorbierbare Mikromembran zur Verminderung von Narbengewebe während des Heilungsprozesses |
US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
WO2002075302A1 (en) * | 2001-03-15 | 2002-09-26 | Xiao Yong Fu | Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
WO2002028472A2 (en) | 2000-10-04 | 2002-04-11 | James Peter Amis | Non-scatterable, radio-opaque marker for medical imaging applications |
FR2819265B1 (fr) * | 2001-01-10 | 2004-01-02 | Centre Nat Rech Scient | Cellules du tissu adipeux extramedullaire et leurs applications dans la reconstitution des lignees hematopoietiques |
US20050008626A1 (en) * | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
CA2849201A1 (en) * | 2001-12-07 | 2003-07-03 | Macropore Biosurgery, Inc. | Adipose-derived cell processing unit |
JP2004099471A (ja) * | 2002-09-05 | 2004-04-02 | Cardio Corp | 心筋梗塞および心不全の治療薬 |
EP2422622B1 (de) * | 2003-02-20 | 2017-01-11 | Cytori Therapeutics, Inc. | Verfahren zur Verwendung von aus Fettgewebe stammenden Zellen bei der Behandlung von Herz-Kreislauf-Leiden |
CN1842589B (zh) * | 2003-06-25 | 2012-04-25 | 马克罗珀尔生物外科公司 | 用于从组织分离并且浓缩再生细胞的系统和方法 |
EP1670315B1 (de) * | 2003-09-17 | 2017-04-19 | Cytori Therapeutics, Inc. | Verfahren zur verwendung von aus fettgewebe stammenden regenerationsfähigen zellen bei der behandlung von peripheren gefässerkrankungen |
CA2550961A1 (en) * | 2003-12-25 | 2005-07-14 | Kanazawa University Technology Licensing Organization Ltd. | Induction of myocardial cell with the use of mammalian bone marrow cell or cord blood-origin cell and fat tissue |
-
2005
- 2005-05-25 EP EP11152868.3A patent/EP2465923B1/de not_active Not-in-force
- 2005-05-25 PL PL05754073T patent/PL1885382T3/pl unknown
- 2005-05-25 AT AT05754073T patent/ATE500319T1/de not_active IP Right Cessation
- 2005-05-25 WO PCT/US2005/018605 patent/WO2006127007A2/en active Application Filing
- 2005-05-25 AU AU2005332046A patent/AU2005332046B2/en not_active Ceased
- 2005-05-25 ES ES05754073T patent/ES2364689T3/es active Active
- 2005-05-25 EP EP05754073A patent/EP1885382B1/de not_active Not-in-force
- 2005-05-25 CA CA2609361A patent/CA2609361C/en not_active Expired - Fee Related
- 2005-05-25 JP JP2008513441A patent/JP5210155B2/ja active Active
- 2005-05-25 KR KR1020137005581A patent/KR101400544B1/ko active IP Right Grant
- 2005-05-25 CN CNA2005800502651A patent/CN101443023A/zh active Pending
- 2005-05-25 DE DE602005026724T patent/DE602005026724D1/de active Active
- 2005-05-25 DK DK05754073.4T patent/DK1885382T3/da active
- 2005-05-25 KR KR1020077030170A patent/KR101278437B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
PL1885382T3 (pl) | 2011-09-30 |
EP1885382A4 (de) | 2009-09-09 |
EP1885382B1 (de) | 2011-03-02 |
ES2364689T3 (es) | 2011-09-12 |
WO2006127007A3 (en) | 2009-04-16 |
KR101400544B1 (ko) | 2014-05-27 |
DK1885382T3 (da) | 2011-06-20 |
WO2006127007A2 (en) | 2006-11-30 |
EP2465923A2 (de) | 2012-06-20 |
AU2005332046A1 (en) | 2006-11-30 |
KR101278437B1 (ko) | 2013-06-25 |
JP2008545687A (ja) | 2008-12-18 |
CA2609361A1 (en) | 2006-11-30 |
EP2465923A3 (de) | 2012-06-27 |
JP5210155B2 (ja) | 2013-06-12 |
CN101443023A (zh) | 2009-05-27 |
EP1885382A2 (de) | 2008-02-13 |
KR20080017389A (ko) | 2008-02-26 |
CA2609361C (en) | 2017-11-14 |
ATE500319T1 (de) | 2011-03-15 |
KR20130038412A (ko) | 2013-04-17 |
AU2005332046B2 (en) | 2013-05-16 |
EP2465923B1 (de) | 2018-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005026724D1 (de) | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz-kreislauf-leiden | |
ATE524070T1 (de) | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden | |
SG146666A1 (en) | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders | |
ATE501247T1 (de) | Verfahren zur verwendung regenerativer zellen zur förderung der wundheilung | |
ATE355852T1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
DE502005010615D1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
DE602006017071D1 (de) | Zusammensetzungen und verfahren zur behandlung von herzkrankheiten | |
DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
EA200971053A1 (ru) | Способы лечения кожных язв | |
MX2019005300A (es) | Polimeros enlazados al proton para administracion oral. | |
MX2018013476A (es) | Composiciones para tratar trastornos acido-base. | |
WO2006022612A3 (en) | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders | |
ATE478942T1 (de) | Verfahren zur verwendung regenerativer zellen bei der behandlung von nierenkrankheiten und störungen | |
ATE484280T1 (de) | Verwendung der kombination aus temozolomid und tnf-alpha zur behandlung von glioblastoma | |
TW201614066A (en) | Composition for treatment of joint disease and method thereof | |
DE602004016547D1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
MX2011011114A (es) | Materiales y metodos para utilizar celulas madre de tejido adiposo para tratar una lesion y enfermedad pulmonar. | |
ATE526984T1 (de) | Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen | |
EA201600229A1 (ru) | Бис(5-амино-1,4-диоксо-1,2,3,4-тетрагидрофталазин-2-ил)цинк, способ его получения, фармацевтическая композиция на его основе, лечебные средства на его основе, способ лечения кожных заболеваний и способ лечения гастрита | |
DE602004015321D1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
ATE511396T1 (de) | Therapeutische zusammensetzungen enthaltend thromboserin oder dessen salze zur verwendung in der prophylaxe oder behandlung von thrombose in patienten mit blutungsrisiko | |
WO2004024041A1 (ja) | 温熱治療方法 | |
GB0501156D0 (en) | General cure to diseases idea 3 |